Acalabrutinib-[d4]

Ask supplier a question | View on supplier's website

Acalabrutinib-[d4] is a labelled version of Acalabrutinib. Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway.

Supplier	BOC Sciences
Product #	BLP-003188
Pricing	Inquire
Molecular Weight	469.53
Molecular Formula	C26H19D4N7O2
Canonical SMILES	CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5

Feedback